Managing Metastatic Bone Pain: The Role of Bisphosphonates Julie Gralow, MD, Debu Tripathy, MD Journal of Pain and Symptom Management Volume 33, Issue 4, Pages 462-472 (April 2007) DOI: 10.1016/j.jpainsymman.2007.01.001 Copyright © 2007 U.S. Cancer Pain Relief Committee Terms and Conditions
Fig. 1 Mean change from baseline in bone pain score for up to 2 years: Phase III intravenous ibandronate trial in patients with advanced breast cancer. Journal of Pain and Symptom Management 2007 33, 462-472DOI: (10.1016/j.jpainsymman.2007.01.001) Copyright © 2007 U.S. Cancer Pain Relief Committee Terms and Conditions
Fig. 2 Mean change from baseline in bone pain score for up to 2 years: Phase III oral ibandronate trial in patients with advanced breast cancer. Journal of Pain and Symptom Management 2007 33, 462-472DOI: (10.1016/j.jpainsymman.2007.01.001) Copyright © 2007 U.S. Cancer Pain Relief Committee Terms and Conditions